We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
AUM
$113M
AUM Growth
-$95.6M
Cap. Flow
-$94M
Cap. Flow %
-82.97%
Top 10 Hldgs %
25.33%
Holding
132
New
13
Increased
4
Reduced
97
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 23.38%
2 Healthcare 14.7%
3 Energy 13.18%
4 Financials 10.77%
5 Communication Services 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
1
Novo Nordisk
NVO
$208B
$5.87M 5.18%
254,000
-50,800
-17% -$1.12M
MSFT icon
2
Microsoft
MSFT
$3.62T
$3.39M 3%
81,344
-82,144
-50% -$3.32M
AFFX
3
DELISTED
Affymetrix Inc
AFFX
$2.73M 2.41%
306,700
-302,300
-50% -$2.41M
FNF icon
4
Fidelity National Financial
FNF
$13.9B
$2.65M 2.34%
141,959
-144,162
-50% -$2.7M
CLMT icon
5
Calumet Specialty Products
CLMT
$3.69B
$2.63M 2.32%
82,781
-84,381
-50% -$2.51M
BTE icon
6
Baytex Energy
BTE
$3.1B
$2.61M 2.31%
56,598
-52,898
-48% -$2.25M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.56T
$2.49M 2.2%
86,216
-67,558
-44% -$1.83M
IMMR icon
8
Immersion
IMMR
$248M
$2.25M 1.99%
176,736
-169,336
-49% -$1.84M
FEIC
9
DELISTED
FEI COMPANY
FEIC
$2.06M 1.82%
22,655
-31,955
-59% -$2.81M
CLB icon
10
Core Laboratories
CLB
$491M
$2M 1.76%
11,958
-12,358
-51% -$2.2M
EPAY
11
DELISTED
Bottomline Technologies Inc
EPAY
$2M 1.76%
66,710
-68,260
-51% -$2.1M
HBIO icon
12
Harvard Bioscience
HBIO
$28.5M
$1.98M 1.75%
43,475
-67,896
-61% -$2.85M
LGCY
13
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$1.94M 1.72%
62,240
-61,940
-50% -$1.72M
ARRS
14
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$1.91M 1.68%
58,567
-62,923
-52% -$1.86M
PRCP
15
DELISTED
Perceptron Inc
PRCP
$1.88M 1.66%
147,458
-146,658
-50% -$1.73M
NUAN
16
DELISTED
Nuance Communications, Inc.
NUAN
$1.85M 1.63%
113,652
-108,859
-49% -$1.58M
AFOP
17
DELISTED
Alliance Fiber Optic Prod Inc
AFOP
$1.84M 1.63%
101,800
+2,075
+2% +$39.2K
XCRA
18
DELISTED
Xcerra Corporation
XCRA
$1.83M 1.62%
201,051
-202,584
-50% -$1.86M
IRBT
19
DELISTED
iRobot
IRBT
$1.81M 1.6%
44,125
-41,275
-48% -$1.49M
TRGP icon
20
Targa Resources
TRGP
$56.8B
$1.72M 1.52%
12,300
-12,400
-50% -$1.43M
ECPG icon
21
Encore Capital Group
ECPG
$2.06B
$1.62M 1.43%
35,684
-36,884
-51% -$1.63M
SNPS icon
22
Synopsys
SNPS
$75.1B
$1.62M 1.43%
41,650
-41,450
-50% -$1.58M
DAIO icon
23
Data I/O
DAIO
$30.4M
$1.61M 1.42%
533,550
-536,650
-50% -$1.44M
AGN
24
DELISTED
Allergan Inc
AGN
$1.57M 1.39%
9,300
-10,700
-54% -$1.67M
ESIO
25
DELISTED
Electro Scientific Industries
ESIO
$1.55M 1.37%
227,560
-104,750
-32% -$836K

Similar funds

Penbrook Management's Q2 2014 Portfolio in Review

As of Q2 2014, Penbrook Management held 132 positions worth $113M, down 46% from $209M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Penbrook Management withdrew a net $94M in Q2 2014, closing 14 positions and reducing 97 holdings. Its most notable exit was NextGen Healthcare, Inc. Common Stock, an estimated $1.15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Penbrook Management opened a new position in EPIQ SYSTEMS INC worth $1.3M.

  • Penbrook Management's largest Q2 2014 buy was EPIQ SYSTEMS INC: 92,800 shares worth $1.3M.
  • Penbrook Management added most to Cyberoptics Corp in Q2 2014, an estimated $47.4K increase.
  • Penbrook Management's biggest Q2 2014 reduction was Microsoft, cutting an estimated $3.32M.
  • Penbrook Management fully exited NextGen Healthcare, Inc. Common Stock in Q2 2014, selling an estimated $1.15M.
  • Penbrook Management's ten largest holdings make up 25% of its $113M portfolio in Q2 2014.
  • Penbrook Management opened 13 new positions and closed 14 in Q2 2014.
  • Penbrook Management's portfolio value fell 46% quarter-over-quarter to $113M.

Based on Penbrook Management's 13F filing for Q2 2014, filed 4 Aug 2014.